Pfizer’s Business Units Enable It To Be Nimble Even as It Grows
Executive Summary
Pfizer's new business unit structure will enable it to become more nimble, fast-moving, and accountable even as it grows bigger following its acquisition of Wyeth, CEO Jeff Kindler argued at an analysts' breakfast March 18
You may also be interested in...
Emerging Pharma Markets: Adapt, Diversify, and Persist
Emerging global markets are a hot topic in pharmaceutical circles these days, but until recently, most Westerners viewed them as a homogenous cluster. Few executives at corporate headquarters drew distinctions among the various countries, let alone the domestic and international players in those markets. As big pharma bumps up against growth constraints in its traditional markets, however, interest in the "rest of the world" is perking up. The largest pharmaceutical companies are all looking at the same promising half dozen or so emerging countries, but they are taking radically different approaches to tackling them and are moving at different paces.
Emerging Pharma Markets: Adapt, Diversify, and Persist
Emerging global markets are a hot topic in pharmaceutical circles these days, but until recently, most Westerners viewed them as a homogenous cluster. Few executives at corporate headquarters drew distinctions among the various countries, let alone the domestic and international players in those markets. As big pharma bumps up against growth constraints in its traditional markets, however, interest in the "rest of the world" is perking up. The largest pharmaceutical companies are all looking at the same promising half dozen or so emerging countries, but they are taking radically different approaches to tackling them and are moving at different paces.
A Goliath Grows: Pfizer To Buy Wyeth For $68 Billion
Pfizer aims to acquire rival Wyeth in a proposed deal valued at approximately $68 billion, broadening Pfizer's leadership position in the market by creating a drug powerhouse with combined sales of more than $71 billion, based on 2008 revenues